Table 1 Baseline characteristics at 2 years after T2DM diagnosis
Characteristics | All subjects (27,871) | Number of complications | ||
|---|---|---|---|---|
None (9130) | 1 (9015) | ≥ 2 (9726) | ||
Age (year) | ||||
Mean ± SD | 57.28 ± 11.97 | 54.30 ± 11.42 | 57.05 ± 11.87 | 60.30 ± 11.84 |
Median, IQR | 57, 48–66 | 53, 46–62 | 56, 48–66 | 61, 52–69 |
< 65 | 19,643 (70.48) | 7327 (80.25) | 6448 (71.53) | 5868 (60.33) |
≥ 65 | 8228 (29.52) | 1803 (19.75) | 2567 (29.47) | 3858 (39.67) |
Gender, n (%) | ||||
Men | 15,132 (54.29) | 5526 (60.53) | 4930 (54.69) | 4676 (48.08) |
Women | 12,639 (45.71) | 3604 (39.47) | 4085 (45.31) | 5050 (51.92) |
CCI, mean ± SD | 2.83 ± 1.77 | 1.66 ± 1.00 | 2.62 ± 1.35 | 4.12 ± 1.82 |
Follow up period, year ±SD | 6.56 ± 2.81 | 6.61 ± 2.86 | 6.56 ± 2.80 | 6.52 ± 2.77 |
Median, IQR | 6.3, 4.1–9.0 | 6.3, 4.1–9.2 | 6.3, 4.2–7.0 | 6.3, 4.1–8.9 |
DCSI, n (%) | 1.44 ± 1.46 | 0 | 1.14 ± 0.36 | 3.05 ± 1.19 |
Comorbidity, n (%) | ||||
Hypertension | 18,657 (66.94) | 5164 (56.56) | 5914 (65.60) | 7579 (77.93) |
Dyslipidemia | 20,225 (72.57) | 5760 (63.09) | 6529 (72.42) | 7936 (81.60) |
Stroke | 2485 (8.92) | – | 423 (4.69) | 2062 (21.20) |
Myocardial infarction | 566 (2.03) | – | 172 (1.91) | 394 (4.05) |
Antidiabetic drug adherence | ||||
Mean ± SD, | 77.86 ± 28.14 | 76.26 ± 28.54 | 77.86 ± 27.99 | 79.36 ± 27.81 |
Median, IQR | 90.41, 66.84–90.41 | 90.13, 65.75–98.63 | 98.63, 66.02–90.41 | 90.41, 71.50–98.63 |
Medications, n (%) | ||||
Antidiabetics | ||||
Metformin | 19,526 (70.06) | 6418 (70.30) | 6403 (71.03) | 6705 (68.94) |
Sulfonylurea | 14,945 (53.62) | 4989 (54.64) | 4774 (52.96) | 5182 (53.28) |
DPP4-I | 4314 (15.48) | 1365 (14.95) | 1439 (15.96) | 1965 (20.20) |
Thiazolidinedione | 1703 (6.11) | 483 (5.29) | 531 (5.89) | 689 (7.08) |
Insulin | 715 (2.57) | 113 (1.24) | 156 (1.73) | 446 (4.59) |
Cardiovascular agents | ||||
Aspirin | 8791 (31.54) | 1761 (19.29) | 2803 (31.09) | 4227 (43.46) |
Clopidogrel | 1754 (6.29) | 31 (0.34) | 462 (5.12) | 1261 (12.97) |
Cilostazol | 1068 (3.83) | 72 (0.79) | 244 (2.71) | 752 (7.73) |
Sarpogrelate | 726 (2.60) | 58 (0.64) | 167 (1.85) | 501 (5.15) |
ACEI/ARB | 13,325 (47.81) | 3534 (38.71) | 4212 (46.72) | 5579 (57.36) |
DHPCCB | 11,336 (40.67) | 3270 (35.82) | 3594 (39.87) | 4472 (45.98) |
Statin | 12,966 (46.52) | 3556 (38.95) | 4081 (45.27) | 5329 (54.79) |